Drug, disease and patient factors involved in the pharmacotherapeutic management of musculoskeletal conditions, reproduction and oncology.
|Paper title||Quality Use of Medicines B|
|Teaching period||First Semester|
|Domestic Tuition Fees (NZD)||$3,126.43|
|International Tuition Fees (NZD)||$15,120.07|
- PHCY 481
- Limited to
- Successful completion of the third-year BPharm programme
Professor Sarah Hook (email@example.com)
- Teaching staff
- Paper Structure
- Three modules:
- Oncology and the immuno-compromised patient (6 weeks)
- Reproduction (3 weeks)
- Musculoskeletal disorders and pain (4 weeks)
- Internal 40%
- Oral Examination 10%
- Final Examination A 20%
- Final Examination B 30%
- Teaching Arrangements
- Lectures, workshop, seminar and laboratories.
- Lemke, T.L & Williams D.A (2013) Foye's Principles of Medicinal Chemistry, 7th edition,
Lippincott Williams & Wilkins.
Chisholm-Burns, M.A. et al (eds)(2013) 3rd edition, Pharmacotherapy Principles and Practice, 3rd edition, McGraw-Hill Companies Inc, USA, 2013 (or later).
Beauchamp, T. & Childress, J. (2008) Principles of Biomedical Ethics, 6th edition, Oxford University Press.
Rutter, P and Newby, D (2012) Community Pharmacy: Symptoms, Diagnosis and Treatment, 2nd edition, Elsevier.
(2011) or later: The Healthcare Handbook, Pharmacy Today
- Graduate Attributes Emphasised
- Lifelong learning, Communication, Critical thinking, Cultural understanding, Ethics,
Information literacy, Research.
View more information about Otago's graduate attributes.
- Learning Outcomes
- The aim of this paper is for students to be able to formulate the components of a
care plan. Pharmaceutical care plans are individualised/patient-focused treatment
strategies developed by clinical pharmacists. A care plan involves the following processes:
- Assessment of the patient
- Formulation of a treatment option
- Enacting this treatment option
- Monitoring the patient's outcomes
- Reflection on outcomes
- Return to "assessment of the patient" and continue the cycle